CHU Saint Etienne
CHU Saint Etienne
Saint-Priest-en-Jarez, France6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. | Advanced Breast Cancer; ER-positive Breast Cancer; ESR1 Gene Mutation; HER2-negative Breast Cancer | Recruiting | Phase 3 | 2026-08-24 | NCT06382948 | |
| A Precision Medicine Trial for Patients With Relapsed or Refractory T Cell ALL | LAL | Not yet recruiting | Phase 2 | 2026-04-17 | NCT07522801 | |
| EURO-STIM Registry | Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, nervous system disorder, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not stated | 2025-09-08 | NCT06971796 | |
| Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells | Solid Tumor, Miscellaneous | Recruiting | Phase 2 | 2025-06-05 | NCT06653777 | |
| Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) | Genital Diseases, Male Urogenital Diseases, Urogenital Diseases, male reproductive system disorder, metastatic prostate carcinoma, prostate disorder | Recruiting | Phase 3 | 2024-12-20 | NCT06496581 | |
| Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR | Prosthetic Infection | Recruiting | Phase 3 | 2022-05-10 | NCT04672525 |